London, UK, 30 April 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of its public offering of 4,000,000 American Depositary Shares (“ADSs”) representing 4,000,000 ordinary shares at a public offering price of $36.00 per ADS for…


Previous articleOp-Ed: Re-evaluating the Results of the Recent Trial of Psilocybin vs Escitalopram for Depression
Next articlePTSF57 – New Compounds, Psychedelic Business, and Neurogenesis